Calming the cytokine storm of COVID-19 through inhibition of JAK2/STAT3 signaling-Reference-Cited by-同舟云学术

Calming the cytokine storm of COVID-19 through inhibition of JAK2/STAT3 signaling

Published:2022-02 Issue:2 Volume:27 Page:390-400
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Gajjela Bharath Kumar,Zhou Ming-Ming^ORCID

Funder

National Institute of Allergy and Infectious Diseases

National Institutes of Health

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference97 articles.

1. WHO. Coronavirus disease (COVID-19). Situation Report – 199. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200806-covid-19-sitrep-199.pdf?sfvrsn=6b9d262d_2. Published August 6, 2020 [accessed May 28, 2021].

2. A novel coronavirus outbreak of global health concern;Wang;Lancet,2020

3. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China;Wang;JAMA,2020

4. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China;Huang;Lancet,2020

5. A novel coronavirus from patients with pneumonia in China, 2019;Zhu;N Engl J Med,2020

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The JAK-STAT pathway: from structural biology to cytokine engineering;Signal Transduction and Targeted Therapy;2024-08-21

2. Network-based Multi-omics Disease–Drug Associations Reveal Drug Repurposing Candidates for Covid-19 Disease Phases;Drug Repurposing;2024-07-03

3. Proteomic snapshot of saliva samples predicts new pathways implicated in SARS-CoV-2 pathogenesis;Clinical Proteomics;2024-05-22

4. Identifying potential monkeypox virus inhibitors: an in silico study targeting the A42R protein;Frontiers in Cellular and Infection Microbiology;2024-03-04

5. Signaling pathways and potential therapeutic targets in acute respiratory distress syndrome (ARDS);Respiratory Research;2024-01-13